Welcome Guest
Home > Clinical Breast Cancer > Volume 2 |  Issue 4

Table of Contents

Volume 2 |  Issue 4

Publication Date: January 2002
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
251		 Hormones ‘R’ Us
George W. Sledge, Jr
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
260-265		 Highlights From: 24th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, December 10-13, 2001
Amy I. D’Orazio, Maxine D. Fisher, Joyce O’Shaughnessy
  • Abstract
  • No Access
  • Add to Cart
Researches in Brief
Page Number of this Article in the Print Version
266-268		 Neoadjuvant Docetaxel Augments the Efficacy of Preoperative Docetaxel/Cyclophosphamide in Operable Breast Cancer: First Results of NSABP B-27
Amy I. D’Orazio, Joyce O’Shaughnessy, Andrew D. Seidman
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
269-271		 Anastrozole May Be Superior to Tamoxifen as Adjuvant Treatment for Postmenopausal Patients with Breast Cancer
Maxine D. Fisher, Joyce O’Shaughnessy, Joseph A. Sparano
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Reviews
Page Number of this Article in the Print Version
272-281		 Selective Estrogen Receptor Modulators as a New Therapeutic Drug Group: Concept to Reality in a Decade
Csaba Gajdos, V. Craig Jordan
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
282-286		 A Rationale for the Reinitiation of Adjuvant Tamoxifen Therapy in Women Receiving Fewer than 5 Years of Therapy
William J. Gradishar, Richard Hellmund
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
287-293		 Taxanes and Capecitabine in Combination: Rationale and Clinical Results
James F. Maher, Miguel A. Villalona-Calero
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
294-298		 Young Age as an Adverse Prognostic Factor in Premenopausal Women with Operable Breast Cancer
Richard R. Love, Nguyen Ba Duc, Nguyen Van Dinh, Tran Tu Quy, Ye Xin, Thomas C. Havighurst
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
299-303		 Phase I/II Trial of Gemcitabine Plus Cyclophosphamide in Patients with Metastatic Breast Carcinoma Previously Treated with Taxanes
Huda S. Salman, Katie Tanaka, Joseph A. Sparano
  • Abstract
  • No Access
  • Add to Cart
Imaging in Breast Cancer
Page Number of this Article in the Print Version
304-310		 Assessment of Response by Breast Helical Computed Tomography to Neoadjuvant Chemotherapy in Large Inflammatory Breast Cancer
Bernard Moyses, Pierre Haegele, Jean-François Rodier, Sylvie Lehmann, Thierry Petit, Michel Velten, Simon Schraub
  • Abstract
  • No Access
  • Add to Cart
Brief Communication
Page Number of this Article in the Print Version
311-315		 Serum Interleukin 6, Plasma VEGF, Serum VEGF, and VEGF Platelet Load in Breast Cancer Patients
Ina Benoy, Roberto Salgado, Cecile Colpaert, Reinhilde Weytjens, Peter B. Vermeulen, Luc Y. Dirix
  • Abstract
  • No Access
  • Add to Cart
Letter to the Editor
Page Number of this Article in the Print Version
316		 Trastuzumab for Breast Cancer–Related Carcinomatous Meningitis
H. Ian Robins, Glenn Liu, Lori Hayes, Minesh Mehta
  • Abstract
  • No Access
  • Add to Cart